Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FM5C9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,187
Award facts
- Contract value 100% obligated
- $11,186.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,186.79 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. Issued on November 28, 2025, with an ultimate completion date of December 1, 2025, this firm fixed-price contract represents a non-competitive set-aside delivery order. The place of performance is listed as the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The vendor's federal contracting history demonstrates consistent success in competitively awarded delivery orders with firm fixed pricing, positioning it as a key supplier for the Department of Defense's pharmaceutical and medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FM5C9?
SPE2DR26FM5C9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FM5C9 worth?
The government has obligated $11,187 on SPE2DR26FM5C9.
Is contract SPE2DR26FM5C9 an order under another contract?
Yes. SPE2DR26FM5C9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM5C9 competed?
The extent of competition for SPE2DR26FM5C9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award